High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902
Titel:
High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902
Auteur:
Stone, Richard M. Moser, Barry Sanford, Ben Schulman, Philip Kolitz, Jonathan E. Allen, Steven Stock, Wendy Galinsky, Ilene Vij, Ravi Marcucci, Guido Hurd, David Larson, Richard A.